Synopsis: A legacy chlor-alkali producer with a five-decade operating history is charting an ambitious growth path, aiming to multiply revenue several times over through capacity expansion, a shift toward higher-margin specialty chemicals, and a sharp push into renewable energy and digital transformation. Here’s a look at what’s driving this next phase.
For decades, this company has quietly powered India’s chemical value chain, supplying raw materials that feed into everything from textiles to pharmaceuticals. Now, with a clear five-year roadmap in place, it’s looking to move beyond its commodity roots and reposition itself as a diversified, technology-driven chemical player with a meaningfully larger revenue base.
With a market capitalization of approximately Rs. 4,333 crore, the shares of Gujarat Alkalies & Chemicals Limited were trading at around Rs. 590 per share with a 52-week range of Rs. 815 to Rs. 409. The stock is down by 25 percent since May 2026.
An Ambitious Growth Target
GACL has laid out a target to grow 2–3x over the next five years, aiming to increase revenue from ₹4,474 crore in FY26 to over ₹10,000 crore by FY31, implying an annual growth rate of nearly 18%, while targeting EBITDA margins above 20%. This marks a meaningful shift in ambition for a company that closed FY26 with revenue of ₹4,474 crore and EBITDA of ₹522 crore, translating to a margin of roughly 11.7%.
The scale-up plan isn’t just aspirational, it’s backed by a board-approved capex pipeline of ₹600–650 crore, with nine growth projects currently in execution, ranging from cell element replacement and caustic soda flaking capacity to HCl synthesis and chlorotoluene downstream units, most of which are expected to be commissioned between late 2026 and early 2027 (FY27).
Moving Up the Value Chain
A key part of this strategy involves diversifying away from pure commodity chemicals toward higher-value specialty products. The company’s board has recently approved projects including Food Grade Phosphoric Acid, E-Grade Hydrogen Peroxide, and a KOH expansion alongside caustic soda lye revamping at its Vadodara facility, with commissioning expected between January 2028 and November 2028.
It has already commissioned a 30,000 TPA chlorotoluene facility in March 2025, while the newly approved specialty chemical projects are scheduled for commissioning between January and December 2028. These moves are aimed at improving the product mix and reducing dependence on cyclical, lower-margin commodity chemicals.
Identifying New Revenue Pools
Much of this transformation is being driven through an internal initiative called Project Ahvaan, undertaken in partnership with global consulting firm A T Kearney since April 2025. Under this program, the company has already identified over ₹5,000 crore of incremental revenue opportunities, with several near-term projects already underway. The initiative rests on three pillars structural cost reduction across power, procurement, and manufacturing; long-term growth and diversification; and organization-wide digital transformation.
Technology as a Margin Lever
On the digital front, the company has earmarked over ₹30 crore for FY27 toward AI and digital initiatives, which management expects could unlock more than ₹50 crore in value. Select use cases are targeted to deliver an EBITDA improvement of 1.5–2.5 percentage points, with an SAP migration already initiated alongside multiple other digital use cases.
Early results from the broader efficiency drive are already visible: EBITDA margin improved by 0.8 percentage points in FY26, power costs fell 6% year-on-year through renewable energy sourcing, and input costs for key raw materials like salt and rock phosphate declined by 1–3% through better procurement.
Greening the Manufacturing Base
Sustainability is also central to this roadmap. The company currently meets around 35% of its power needs through renewable sources, comprising 171.45 MW of existing wind, 36.42 MW of existing solar, 37.5 MW of GIPCL solar, and 150 MW of short-term solar, and is targeting over 70% by FY28. By then, renewable capacity is expected to scale to 207.87 MW of existing RE, alongside 138.6 MW from ABRen Hybrid and Cleanmax, roughly 40 MW of additional hybrid capacity, and about 60 MW of solar paired with battery energy storage systems, with several long-term power partnerships currently under discussion with players like CleanMax, Fourth Partner Energy, Tata Power, and Sembcorp.
The Foundation for This Push
This next phase of growth isn’t starting from scratch. The company is India’s largest producer of 60,600 TPA phosphoric acid and the country’s sole producer of 10,000 TPA hydrazine hydrate. It also ranks among the top five domestic manufacturers of 873,750 TPA caustic soda, 161,100 TPA chloromethanes, and 54,120 TPA hydrogen peroxide.
With an annual caustic soda capacity of 0.87 million tonnes (including its subsidiary GNAL) and over 50 years of operating history across its Vadodara and Dahej complexes, the company has an established manufacturing platform to build this expansion on.
Investor Verdict
The scale of ambition here is notable; more than doubling revenue in five years is no small task, and execution risk on nine simultaneous projects, alongside broader chemical sector demand cycles, will be worth watching closely.
That said, the combination of identified revenue pools, board-approved capex, a clear specialty chemicals push, and cost efficiencies already showing up in FY26 numbers gives this roadmap more substance than a typical aspirational target. Investors will likely want to track quarterly execution updates on the ₹650 crore capex pipeline as the real test of whether this transformation delivers.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
